Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently sold shares in the company amounting to $146,205. The transaction involved the sale of 6,667 shares of ...
Hosted on MSN15d
Enliven Therapeutics CFO sells $22,524 in stockBenjamin Hohl, the Chief Financial Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), a biotechnology company with a market capitalization of $1.07 billion, recently executed a series of stock ...
Enliven Health and Wellness Comprehensive Care approaches the health and wellness of our clients holistically, giving equal attention to mental and physical challenges. We believe that true ...
In other recent news, Enliven Therapeutics has received favorable ratings from several analyst firms, including BTIG and Clear Street, which initiated coverage with a Buy rating and price targets ...
根据提交给美国证券交易委员会的Form 4文件显示，市值10.7亿美元的生物科技公司Enliven Therapeutics, Inc. (NASDAQ: ELVN )首席财务官Benjamin Hohl近期进行了一系列股票交易。根据InvestingPro数据，该公司整体财务健康状况评级为"良好"。2月5日，Hohl以平均价格22.52美元出售了1,000股普通股，总售价为22,524美元。
Enliven Therapeutics, Inc. (NASDAQ: ELVN )首席运营官Anish Patel近期出售了公司股票，交易总额达$146,205。此次交易涉及以平均每股$21.9298的价格出售6,667股普通股，于2025年2月7日根据预先制定的Rule 10b5-1交易计划执行。根据 InvestingPro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback